BioXcel Therapeutics, Inc. (BTAI) Discuses On SERENITY At-Home Pivotal Phase 3 Safety Trial Results Call (Transcript)

September 10, 2025 06:41:42 pm

Source: SeekingAlpha

2025-09-10 18:41:42 ET

BioXcel Therapeutics, Inc. (BTAI) Discuses on SERENITY At-Home Pivotal Phase 3 Safety Trial Results Conference September 10, 2025 02:00 PM ET...

For further details see:

BioXcel Therapeutics Inc.

1.06% G/L:

$1.425 Last:

213,719 Volume:

$1.45 Open:

March 25, 2026 06:32:53 pm

March 11, 2026 04:20:00 pm

March 10, 2026 02:36:00 pm

March 05, 2026 09:35:18 am

Market Cap $36,631,397

Float 21,060,320

Insiders Ownership 0.54%

Institutions 17

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City New Haven